XML 47 R35.htm IDEA: XBRL DOCUMENT v3.25.1
Stockholders’ Equity (Details) - USD ($)
3 Months Ended
Apr. 06, 2022
Mar. 31, 2025
Mar. 31, 2024
Dec. 31, 2024
May 31, 2023
May 31, 2022
May 31, 2021
Dec. 31, 2014
Stockholders’ Equity [Line Items]                
Shares issued for exercise of options   3,017,420            
Proceeds from exercise options (in Dollars)   $ 246,747          
Research and development compensation expense (in Dollars)   $ 905,226            
Term of stock options   10 years            
Exercise price per share (in Dollars per share)   $ 0.3            
Aggregate fair value of options (in Dollars)   $ 54,963            
Expected life   6 years 3 months            
Expected dividends   0.00%            
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Vested (in Dollars)   $ 0            
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value (in Dollars)   0            
Warrants [Member]                
Stockholders’ Equity [Line Items]                
Unrecognized stock-based compensation expense (in Dollars)   $ 112,300            
Stock Option [Member]                
Stockholders’ Equity [Line Items]                
Common stock grants   13,052,942            
Term of stock options   6 years 7 days            
Vested term   4 years            
Options issued   203,567            
Stock option term   10 years            
Vesting period   4 years            
Unrecognized stock-based compensation expense (in Dollars)   $ 12,800,000            
Weighted average remaining service period   1 year 11 months 26 days            
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value (in Dollars)            
2014 Stock Option and Equity Incentive Plan [Member]                
Stockholders’ Equity [Line Items]                
Common stock grants               5,152,942
Common Stock [Member]                
Stockholders’ Equity [Line Items]                
Shares issued for exercise of options     74,999          
Common Stock [Member] | Stock Option [Member]                
Stockholders’ Equity [Line Items]                
Shares issued for exercise of options     74,999          
Proceeds from exercise options (in Dollars)     $ 246,747          
Open Market Sale Agreement [Member] | Common Stock [Member]                
Stockholders’ Equity [Line Items]                
Aggregate offering price (in Dollars) $ 100,000,000              
Number of shares issued              
2021 Equity Incentive Plan [Member]                
Stockholders’ Equity [Line Items]                
Issuance of common stock         2,500,000 3,900,000    
2021 Equity Incentive Plan [Member] | Stock Option [Member]                
Stockholders’ Equity [Line Items]                
Common stock grants             1,500,000  
Black-Scholes Option-Pricing Model [Member]                
Stockholders’ Equity [Line Items]                
Expected life   6 years 3 months            
Expected volatility   126.00%            
Expected dividends   0.00%            
Minimum [Member] | Black-Scholes Option-Pricing Model [Member]                
Stockholders’ Equity [Line Items]                
Discount rate   4.05%            
Maximum [Member]                
Stockholders’ Equity [Line Items]                
Expected volatility   135.00%            
Maximum [Member] | Black-Scholes Option-Pricing Model [Member]                
Stockholders’ Equity [Line Items]                
Discount rate   4.16%